MEDP
Medpace Holdings, Inc. · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 45.76K | $27.51M | n/a | n/a |
| Q2 2026 | 131 | -10 | 16.80M | $8.90B | +3 | −12 |
| Q1 2026 | 143 | -2 | 15.75M | $7.54B | +5 | −8 |
| Q4 2025 | 145 | 0 | 17.01M | $9.56B | +1 | n/a |
| Q3 2025 | 22 | 0 | 10.56M | $5.42B | +1 | −2 |
| Q2 2025 | 20 | +1 | 9.67M | $3.03B | +1 | n/a |
| Q1 2025 | 16 | -1 | 3.77M | $1.14B | n/a | −1 |
| Q4 2024 | 17 | +1 | 4.06M | $1.35B | +1 | n/a |
| Q3 2024 | 15 | -1 | 3.56M | $1.19B | n/a | −1 |
| Q2 2024 | 16 | n/a | 3.05M | $1.26B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 24.77K | -52.0% | $15.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 20.82K | +30.8% | $11.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 170 | +39.3% | $101,590 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 724 holders, 23.89M shares, $10.71B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director, 10% owner · 21.97K sh · $13.74M
Officer, Director, 10% owner · 26.70K sh · $16.58M
Officer, Director, 10% owner · 2.41K sh · $1.49M
Officer, Director, 10% owner · 154 sh · $95,572
Officer, Director, 10% owner · 27.83K sh · $17.29M
Officer, Director, 10% owner · 16.08K sh · $10.11M
Officer, Director, 10% owner · 49.02K sh · $30.79M
Officer, Director, 10% owner · 21.88K sh · $13.64M
Officer, Director, 10% owner · 10.88K sh · $6.75M
Officer, Director, 10% owner · 8.77K sh · $5.45M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
19.1% of class · View original SEC filing ↗